CS MEDICA A/S

Recommendation

Buy

Price Target

€2.30

Upside

379.17%

Chart
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 3Y

€0.48

€0.01 (2.99%)
Realtime-Data from Invalid Date
CS MEDICA is a Danish Med-Tech company founded in 2011. It researches and utilizes different compounds found in the cannabis plant and thereby has created 10+ products that effectively and safely treat autoimmune and stress-related disorders from arthritis and psoriasis to hair loss as well as wound and pain care. Its vision is to innovate the current landscape of alternative pharmacological and medical treatments by making use of the ingredient CBD in its products in the form of gels, creams, and sprays, and showcasing equal to superior efficacy and fewer side effects when compared to conventional products.
Ticker
8G8 GR
Market Cap
€8.21 M
Enterprise Value
€9.44 M
26 week avg vol.
1500
Primar Exchange
Xetra
IPO
2021
Sector
Health Care & Pharma
Headquarters
Copenhagen, DK
Employees
16
Incorporated
2011
CEO
Lone Henriksen
Lone Henriksen
33.87%
Gitte Henriksen
32.88%
Finn-Ove Henriksen and Nina Henriksen
3.34%
Diaz Capital Invest AB
3.16%
14.11.2024
Publication of annual report
28.11.2024
Publication of annual report
17.12.2024
Annual General Meeting

KPIs in DKK

KPI20232024e2025e
Sales1.07 M16.15 M33.83 M
EBITDA(15.82 M)(11.95 M)(3.38 M)
EBIT(17.90 M)(14.05 M)(5.75 M)
EPS(1.18)(1.08)(0.78)
FCF(10.52 M)(19.71 M)(9.64 M)

Valuation

KPI20232024e2025e
EV / Sales65.96x5.58x2.95x
EV / EBITDA(4.45x)(7.54x)(29.49x)
EV / EBIT(3.93x)(6.41x)(17.35x)
Price / Earnings(3.04x)(3.32x)(4.61x)
EV / FCF(6.69x)(4.57x)(10.35x)

Downloads

Latest Research
Initiation

Analyst

Christian Sandherr

Equity Research

Latest Research

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.